Lipid Nanoparticles as Delivery Systems for RNA-Based Vaccines

There has been increased interest in the development of RNA-based vaccines for protection against various infectious diseases and also for cancer immunotherapies. Rapid and cost-effective manufacturing methods in addition to potent immune responses observed in preclinical and clinical studies have m...

Descripción completa

Detalles Bibliográficos
Autores principales: Aldosari, Basmah N., Alfagih, Iman M., Almurshedi, Alanood S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913163/
https://www.ncbi.nlm.nih.gov/pubmed/33540942
http://dx.doi.org/10.3390/pharmaceutics13020206

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913163/
https://www.ncbi.nlm.nih.gov/pubmed/33540942
http://dx.doi.org/10.3390/pharmaceutics13020206

Ejemplares similares